NVR, clears the business-activity screen and the figures we can measure look clean, but one or more financial figures are still pending, so the verdict is not final yet.
NVR, Inc.
NVR · a US exchange · USD · Market cap $15.6B · 6,300 employees
NVR, Inc.
Not yet scoredPrice as of 19 Nov 2026Daily close, not a live quote
Screened 2026-11-19 · the tape above runs as of 08:05 UTC · two dates, stated on purpose · verdict and workings shown in full · never trimmed
Key facts today
- Price5,494.21 USD at the 19 Nov 2026 close
- Our value readOvervalued vs our fair value, as of 19 Nov 2026
- Our regime readDistribution, as of 15 Nov 2026
- Ethical screenNot yet scored
- Last reviewed19 Nov 2026 (1 day ago)
- Release timesRelease and earnings times on your chart: Event Guard Mentor
A summary of the dated readings below, not a live quote and not advice.
Our fair-value range: $4,377.60 to $5,328.71, base estimate $4,633.66 (screen dated 2026-11-19).
- Trend Distribution
- Insiders no filings inside 60 days, left as found
- Positioning political selling, disclosed 2026-10-13
- Options no verdict drawn today, left as found
- Ethical screen not yet scored
Our analytic regime reads on this name, dated and marked against the screened price. Small sample per name, and separate from the daily-framework accuracy on the Track Record page.
This name holds its distribution label.
NVR, Inc. holds its Distribution at $5,494.21. The statistical read favours the sellers, held for 19 days.
| Phase | Distribution · caution |
| Quantitative state | The statistical read favours the sellers, held for 19 days |
| Price at the screen | $5,494.21 |
| Valuation | 16.30 trailing · 17.02 forward price to earnings |
| Values screen | Not scored · score 84.9 |
| Beta | 0.94 |
Five Screens: NVR's Results
This security has not been fully scored against the values screen yet.
| Test | Figure | Limit | Status |
|---|---|---|---|
| Business activity | Permissible | Permissible core business | Pass |
| Debt load | 17.98% | Below 33% | Pass |
| Interest-bearing cash | 0.00% | Below 33% | Pass |
| Receivables | 33.28% | Below 49% | Pass |
Definitions, sources and threshold rules: ticker values-screen methodology.
The Ethical ReadThe Read, in Plain English
NVR, clears the business-activity screen and the figures we can measure look clean, but one or more financial figures are still pending, so the verdict is not final yet.
Read as at 2026-11-19. It updates when the underlying figures move, and past reads are kept below.
NVR, clears all five screens. Its business is in a permissible area, its interest-bearing debt is about 18%, inside the ~33% line, and almost none of its income is interest, so it passes.
Earlier reads, kept as written. The ethical profile is tracked over time, not overwritten.
What the Numbers Say It Is WorthThe Fair Value Range
Our analysis reads Overvalued vs our fair value, as of 19 Nov 2026: it trades above our $4,633.66 fair value estimate, moderate competitive moat.
Model construction and limits: fair-value methodology.
Fair value range in USD, drawn from the 2026-11-19 screen. The gold marker is the market price at the same screen. The price runs 18.6% above the base estimate.
Third-party analyst targets: 6 covering, consensus Hold. The average target sits +12% from the screen price.
Reading the gap · Our more conservative model reads it as fully-to-richly valued here, while the Street is more bullish: a quality-at-a-fair-price name rather than a deep-value one.
Price History & ProjectionsWhere our models see it going: fair-value estimate $4,633.66, with a range of $4,377.60 to $5,328.71, dated to the 2026-11-19 screen.
How our estimate and third-party targets differ.
The Business, in Plain WordsHomebuilder Keeps Building Through the Slowdown
When families still need a roof even as borrowing costs rise, NVR keeps turning land into homes across the United States. The business delivers a 33 percent return on equity and 12 percent profit margins while holding a moderate competitive edge. Forward earnings sit at 15.5 times despite revenue falling 21 percent, and the ethical screen raises no flags.
That combination of efficiency and clean governance marks the case for watching the name. Shares trade above our fair value yet the cyclical residential sector rarely stays down forever. A hold rating from five analysts leaves the door open if volumes recover.
The obvious risk is the cycle itself. Revenue already sliding hard and a negative margin of safety mean any further slowdown in buyer demand could pressure results quickly. Analysis, not advice.
| Forward P/E | 17.0xreasonably valued |
| Trailing P/E | 16.3xreasonably valued |
| EPS, trailing | 361.76 |
| EPS, forward | 346.37 |
| Revenue growth | -8.2%revenue is shrinking |
| Profit margin | 11.1%thin but positive margins |
| Return on equity | 28.3%an exceptional return on shareholder capital |
| FCF yield | 4.53% |
| Debt to equity | 0.32minimal debt: a conservative balance sheet |
| Current ratio | 5.39comfortably covers its short-term bills |
| Beta | 0.94steadier than the market |
| Short interest, float | 0.10% |
| 52-week range | 5,501.01 - 8,200.00 |
| Moat | MODERATE |
| Market cap | $15.6B |
| Employees | 6,300 |
Metric definitions and interpretation rules: ticker-page methodology.
Every Entry, As Written
The framework has shifted from markup to distribution since the last review. Smart money appears to be selling into strength. Institutional holders may be rotating out. Price has moved down 8.2% since our last review. Ethical screening: not fully scored yet. The risk-adjusted return profile shows modest positive risk-adjusted returns. Our composite framework grades it C, carrying a low risk profile. Technically it is sitting below its long-term trend line with momentum reading bullish. Over the past year the shares are down 15%. Our forward projection puts the odds of a 10% gain over the next month near 11%. The street (6 analysts) rates it hold, with a mean price target of $6230.
The framework has shifted from distribution to markup since the last review. Price is trending higher with momentum. The crowd has caught on and buyers are in control. Price has moved up 6.6% since our last review. Ethical screening: not fully scored yet. The risk-adjusted return profile shows modest positive risk-adjusted returns. Our composite framework grades it C, carrying a low risk profile. Technically it is sitting below its long-term trend line with momentum reading neutral. Over the past year the shares are down 15%. Our forward projection puts the odds of a 10% gain over the next month near 11%. The street (6 analysts) rates it hold, with a mean price target of $6230.
The framework has shifted from markdown to distribution since the last review. Smart money appears to be selling into strength. Institutional holders may be rotating out. Price has moved up 1.1% since our last review. Ethical screening: not fully scored yet. The risk-adjusted return profile shows modest positive risk-adjusted returns. Our composite framework grades it C, carrying a low risk profile. Technically it is sitting below its long-term trend line with momentum reading neutral. Over the past year the shares are down 15%. Our forward projection puts the odds of a 10% gain over the next month near 11%. The street (6 analysts) rates it hold, with a mean price target of $6262.
The analysis reads markdown. Price is trending lower. Sellers are in control and the prior trend has reversed. Price has moved down 0.0% since our last review. Ethical screening: not fully scored yet. The risk-adjusted return profile shows modest positive risk-adjusted returns. Our composite framework grades it C, carrying a low risk profile. Technically it is sitting below its long-term trend line with momentum reading bearish. Over the past year the shares are down 15%. Our forward projection puts the odds of a 10% gain over the next month near 11%. The street (6 analysts) rates it hold, with a mean price target of $6395. It reported earnings in this window, a natural checkpoint for the thesis.
The analysis reads markdown. Price is trending lower. Sellers are in control and the prior trend has reversed. Price has moved down 0.0% since our last review. Ethical screening: PASS with strong ethical credentials. The risk-adjusted return profile shows modest positive risk-adjusted returns. Our composite framework grades it C, carrying a low risk profile. Technically it is sitting below its long-term trend line with momentum reading bearish. Over the past year the shares are down 15%. Our forward projection puts the odds of a 10% gain over the next month near 11%. The street (6 analysts) rates it hold, with a mean price target of $6395. It reported earnings in this window, a natural checkpoint for the thesis.
The analysis reads markdown. Price is trending lower. Sellers are in control and the prior trend has reversed. Price has moved down 0.0% since our last review. Ethical screening: PASS with strong ethical credentials. The risk-adjusted return profile shows modest positive risk-adjusted returns. Our composite framework grades it C, carrying a low risk profile. Technically it is sitting below its long-term trend line with momentum reading bearish. Over the past year the shares are down 15%. Our forward projection puts the odds of a 10% gain over the next month near 11%. The street (6 analysts) rates it hold, with a mean price target of $6395. It reported earnings in this window, a natural checkpoint for the thesis.
The analysis reads markdown. Price is trending lower. Sellers are in control and the prior trend has reversed. Price has moved down 0.0% since our last review. Ethical screening: PASS with strong ethical credentials. The risk-adjusted return profile shows modest positive risk-adjusted returns. Our composite framework grades it C, carrying a low risk profile. Technically it is sitting below its long-term trend line with momentum reading bearish. Over the past year the shares are down 15%. Our forward projection puts the odds of a 10% gain over the next month near 11%. The street (6 analysts) rates it hold, with a mean price target of $6395. It reported earnings in this window, a natural checkpoint for the thesis.
The analysis reads markdown. Price is trending lower. Sellers are in control and the prior trend has reversed. Price has moved down 0.0% since our last review. Ethical screening: PASS with strong ethical credentials. The risk-adjusted return profile shows modest positive risk-adjusted returns. Our composite framework grades it D, carrying a low risk profile. Technically it is sitting below its long-term trend line with momentum reading neutral. Over the past year the shares are down 15%. Our forward projection puts the odds of a 10% gain over the next month near 11%. The street (6 analysts) rates it hold, with a mean price target of $6395. It reported earnings in this window, a natural checkpoint for the thesis.
The analysis reads markdown. Price is trending lower. Sellers are in control and the prior trend has reversed. Price has moved down 0.4% since our last review. Ethical screening: PASS with strong ethical credentials. The risk-adjusted return profile shows modest positive risk-adjusted returns. Our composite framework grades it D, carrying a low risk profile. Technically it is sitting below its long-term trend line with momentum reading neutral. Over the past year the shares are down 15%. Our forward projection puts the odds of a 10% gain over the next month near 11%. The street (6 analysts) rates it hold, with a mean price target of $6395. It reported earnings in this window, a natural checkpoint for the thesis.
The analysis reads markdown. Price is trending lower. Sellers are in control and the prior trend has reversed. Price has moved up 0.7% since our last review. Ethical screening: PASS with strong ethical credentials. The risk-adjusted return profile shows modest positive risk-adjusted returns. Our composite framework grades it D, carrying a low risk profile. Technically it is sitting below its long-term trend line with momentum reading neutral. Over the past year the shares are down 15%. Our forward projection puts the odds of a 10% gain over the next month near 11%. The street (6 analysts) rates it hold, with a mean price target of $6395. It reported earnings in this window, a natural checkpoint for the thesis.
Each entry above was written on its date, before the outcome. A journal you can prune is not a journal.
- Existing-Home Sales Fall to Lowest Level Since 2010 as Mortgage Rates Take Their Toll Yahoo Finance · 8d ago
- What Sent Lennar Stock Lower On Tuesday? Yahoo Finance · 9d ago
- 3 Stocks Wall Street Likes More Than the Market Does Yahoo Finance · 9d ago
- What Invesco S&P 500 Equal Weight ETF (RSP) Bought: Moderna Leads on Nov. 6 Yahoo Finance · 10d ago
- Premarket movers: Nvidia slides on Huang probe, NVR extends rally Yahoo Finance · 11d ago
Headlines from third-party outlets, linked for reference: not our reporting, not advice.
Screened names in the same industry · explore each on its own page.
| Date | Insider | Title | Type | Shares | Value |
|---|---|---|---|---|---|
| 2026-04-24 | DEVITO MICHAEL J. | Director | 11 | $73,694 | |
| 2026-02-20 | ANDREWS CHARLES ELLIOTT JR | Director | 5 | · | |
| 2026-02-13 | ROSS SUSAN WILLIAMSON | Director | 200 | $1,584,412 | |
| 2026-02-13 | ROSS SUSAN WILLIAMSON | Director | 200 | $340,000 | |
| 2026-02-10 | KELPY MATTHEW B. CPA | Officer | 500 | $4,050,000 | |
| 2026-02-10 | KELPY MATTHEW B. CPA | Officer | 500 | $2,237,765 | |
| 2026-02-05 | ROSS SUSAN WILLIAMSON | Director | 200 | $1,618,324 | |
| 2026-02-05 | ROSS SUSAN WILLIAMSON | Director | 200 | $340,000 | |
| 2026-02-04 | ROSS SUSAN WILLIAMSON | Director | 220 | $1,760,000 | |
| 2026-02-04 | ROSS SUSAN WILLIAMSON | Director | 220 | $374,000 |
Public filings, recorded as found. The full tape lives at Insider Intelligence.
| Date | Politician | Party | Type | Amount |
|---|---|---|---|---|
| 2026-10-13 | Ro Khanna | Democrat | sell | 1K–15K |
| 2026-09-11 | Ro Khanna | Democrat | buy | 1K–15K |
| 2026-09-11 | Ro Khanna | Democrat | buy | 1K–15K |
| 2026-09-11 | Ro Khanna | Democrat | buy | 1K–15K |
| 2026-09-11 | Ro Khanna | Democrat | buy | 1K–15K |
| Period | Price then | Price return | Divs per share | $1,000 became | Total return |
|---|---|---|---|---|---|
| 1 month | $5,828.00 | -3.4% | · | $966 | -3.4% |
| 2 months | $6,150.47 | -8.5% | · | $915 | -8.5% |
| 3 months | $6,300.00 | -10.7% | · | $893 | -10.7% |
| 6 months | $6,036.99 | -6.8% | · | $932 | -6.8% |
| 1 year | $7,147.13 | -21.3% | · | $788 | -21.3% |
| 2 years | $8,865.63 | -36.5% | · | $635 | -36.5% |
| 3 years | $6,298.00 | -10.6% | · | $894 | -10.6% |
| 5 years | $5,216.01 | +7.9% | · | $1,079 | +7.9% |
Historical returns from market close data. Past performance does not guarantee future results.
This entry now belongs to the ledger. Whatever NVR does next, these words stay.
Thirteen thousand names carry this page. One desk keeps them honest.
Membership opens the full screen archive, the composites built from it, and the daily coverage that prices what the screen approves.
Join the deskScreening is research, not a fatwa and not financial advice. Figures are drawn from public accounts at the screen date shown. Always manage your risk.